Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23241,79,1.08 [0.72-1.63],0.7115289664710549
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23728,126,0.88 [0.60-1.30],0.519219801033354
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23519,867,0.97 [0.85-1.11],0.630441100352328
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Candidiasis,23745,261,1.07 [0.86-1.34],0.5293283253527199
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23070,2337,0.96 [0.88-1.04],0.3417880453038266
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23292,1765,0.95 [0.86-1.05],0.2981308179524917
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23574,844,0.93 [0.81-1.07],0.3111461678557605
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23682,37,1.03 [0.55-1.92],0.9201395694399692
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,22662,538,0.94 [0.78-1.12],0.4662481053671355
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21906,516,1.01 [0.85-1.20],0.907354685163285
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22122,148,1.13 [0.86-1.50],0.3849584425819775
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,17617,1023,0.92 [0.81-1.04],0.1919920929027776
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,21925,249,0.92 [0.71-1.20],0.5297061879553764
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23718,988,0.96 [0.85-1.09],0.5648745071177987
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Mycoses,23801,317,1.06 [0.86-1.30],0.5948836859161881
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23180,528,1.05 [0.90-1.23],0.5455211297071816
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23751,589,0.96 [0.81-1.13],0.6103011407495659
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22858,128,0.87 [0.59-1.28],0.4872271823529213
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23842,28,1.05 [0.52-2.14],0.8854397524760658
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23681,519,0.97 [0.82-1.16],0.7657715833148528
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23709,64,0.81 [0.45-1.43],0.4636120972866026
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23752,152,1.06 [0.80-1.42],0.6788414322839718
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23738,138,1.02 [0.74-1.40],0.9017110156727944
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22946,294,1.07 [0.87-1.32],0.4971476927516234
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22858,206,0.69 [0.49-0.98],0.0399145134275776
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22797,67,1.21 [0.83-1.78],0.3250330126258819
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23816,43,0.89 [0.46-1.73],0.7374614533936067
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23787,112,1.00 [0.69-1.43],0.9901455925353057
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Viral warts,23712,37,0.70 [0.31-1.57],0.3838096812624705
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23718,43,1.28 [0.83-1.99],0.2647442846628395
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm,23585,271,1.02 [0.82-1.28],0.833037154593835
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23765,62,1.03 [0.65-1.64],0.8847553119557859
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23740,66,1.12 [0.74-1.70],0.5787463167779027
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10630,36,1.10 [0.63-1.91],0.7318902783415712
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23663,997,0.97 [0.86-1.10],0.686952295347426
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of meninges,23831,44,0.78 [0.39-1.57],0.4845734221800447
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23811,46,0.78 [0.40-1.55],0.4843903535742486
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23822,79,1.09 [0.73-1.61],0.6859285868939982
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm of ovary,13155,83,0.97 [0.64-1.47],0.8815490444947248
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23834,234,1.10 [0.87-1.39],0.4193775488053253
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Caecum,23830,181,1.16 [0.91-1.49],0.2314018476033679
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23775,45,1.01 [0.56-1.79],0.9857580731004476
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Descending colon,23838,154,0.91 [0.65-1.29],0.6016126107074026
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Rectum,23804,242,0.87 [0.66-1.16],0.3479158606431249
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23772,465,1.06 [0.89-1.25],0.5364998875607647
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23834,259,0.92 [0.71-1.20],0.5271322471947009
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Carcinoma in situ of breast,11293,74,0.79 [0.46-1.35],0.3859836281454265
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11332,84,0.89 [0.56-1.41],0.6167649606063995
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",20582,31,0.74 [0.31-1.79],0.5030047482166671
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",20584,33,0.83 [0.38-1.81],0.64524492517043
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23803,93,1.10 [0.77-1.58],0.6032836288944303
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Haemangioma, any site",23803,91,1.11 [0.77-1.59],0.5802560670841496
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Leiomyoma of uterus,12603,340,1.01 [0.83-1.23],0.9099662073018384
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Lung cancer and mesothelioma,17659,147,0.97 [0.70-1.33],0.8281603461947913
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Lymphoid leukaemia,20577,26,0.82 [0.34-2.00],0.6612594227898734
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",20678,127,1.19 [0.90-1.57],0.2109475797653641
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",20626,75,0.80 [0.47-1.37],0.4187220254669496
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11378,66,1.39 [1.00-1.92],0.0476707586250991
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",20596,45,1.20 [0.73-1.95],0.4716045167570373
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",20601,50,1.55 [1.14-2.11],0.0049599446465918
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",20614,63,1.27 [0.85-1.90],0.2488200759590719
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11359,47,1.30 [0.85-2.00],0.2244618088703533
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",20600,49,0.62 [0.29-1.33],0.2186618106330399
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9580,341,0.89 [0.70-1.12],0.3089647324141384
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",20635,84,0.88 [0.55-1.42],0.601595285343391
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",20597,46,0.69 [0.33-1.47],0.3355501870399203
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,20607,56,0.96 [0.56-1.63],0.8723837639303453
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi,23642,190,0.70 [0.50-1.00],0.0468863722772173
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanocytic naevi of trunk,23803,87,0.56 [0.31-0.98],0.0441573418658573
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Melanoma in situ,20559,37,0.55 [0.23-1.32],0.1772505936785792
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",20604,53,0.93 [0.53-1.64],0.8048241913291966
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",20651,100,1.07 [0.74-1.53],0.7291634428851137
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",20649,98,0.65 [0.37-1.13],0.1278618872184279
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",20607,56,0.84 [0.46-1.52],0.5675576290289898
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,Other benign neoplasms of skin,23685,128,0.95 [0.67-1.35],0.7813372023130565
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21101,550,1.05 [0.90-1.23],0.5471996865665272
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21131,580,1.09 [0.95-1.27],0.225296618939778
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23596,255,1.04 [0.82-1.31],0.7436719062098174
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22623,39,1.42 [0.92-2.17],0.1096764082003741
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23407,66,1.10 [0.71-1.70],0.6581019541246688
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23145,1905,1.11 [1.03-1.20],0.0080433172679274
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22853,19,0.82 [0.28-2.36],0.7073685556305794
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23540,28,1.41 [0.90-2.21],0.1385834193146274
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23458,874,1.11 [0.99-1.25],0.0843163328504732
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23458,874,1.11 [0.99-1.25],0.0843163328504732
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22632,48,0.86 [0.45-1.63],0.6406650911577896
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23604,770,1.07 [0.95-1.22],0.2689646321003629
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23600,88,1.18 [0.84-1.65],0.3518359174840169
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23388,47,1.45 [1.02-2.07],0.0375271670172528
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23379,38,1.29 [0.81-2.07],0.2852889240387389
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23677,165,1.30 [1.04-1.63],0.0199708806170661
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23772,60,1.22 [0.84-1.79],0.2994152397941385
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23654,142,1.36 [1.09-1.71],0.0071243127478833
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22892,58,1.00 [0.60-1.65],0.9942971421105936
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,20448,176,1.04 [0.78-1.39],0.7715896883294799
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22166,104,0.89 [0.56-1.42],0.6364983830910862
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22184,122,0.99 [0.72-1.38],0.9697312432716874
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20303,31,1.06 [0.53-2.09],0.876221319458843
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22126,64,0.84 [0.48-1.46],0.5325233689759935
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21820,126,1.29 [1.00-1.66],0.0537730933799082
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23714,139,0.84 [0.57-1.24],0.3837938835010475
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23620,45,0.95 [0.53-1.71],0.872452112429984
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,23607,32,1.50 [0.99-2.28],0.0587599411354095
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23488,1426,0.90 [0.81-1.01],0.0714157272705389
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21349,1386,0.90 [0.81-1.01],0.0619756270248317
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20311,39,0.49 [0.20-1.22],0.1245861363498395
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",22422,50,1.01 [0.59-1.74],0.9658891760189432
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,20432,160,0.98 [0.71-1.34],0.8809149906593254
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20325,53,0.53 [0.25-1.13],0.1027490464573923
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,22349,2077,1.01 [0.93-1.10],0.7663268784259161
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,20378,106,0.95 [0.64-1.41],0.7883317246184578
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,20609,337,0.93 [0.74-1.16],0.5208495744496267
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23760,226,1.07 [0.84-1.35],0.5800529556171545
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23626,92,1.06 [0.72-1.54],0.7781800010346103
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20362,90,1.02 [0.69-1.51],0.9127740595187506
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20306,34,1.24 [0.71-2.16],0.4479447912163624
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23472,1100,0.99 [0.88-1.11],0.853807596967474
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,20381,109,1.08 [0.77-1.52],0.6475392908860597
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,20400,128,0.91 [0.62-1.32],0.616817988171027
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",20614,342,0.93 [0.74-1.17],0.5231344158446488
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20328,56,1.04 [0.62-1.73],0.889084322489385
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23620,86,1.11 [0.77-1.61],0.567361408599032
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,20532,260,1.23 [1.01-1.50],0.0410534672663171
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,20540,268,1.03 [0.82-1.30],0.8052352676804664
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21742,48,1.48 [1.07-2.05],0.0187608416429122
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23238,2966,1.02 [0.95-1.10],0.5124124894500317
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,22395,23,1.03 [0.48-2.19],0.9437931962361192
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,22424,52,1.15 [0.74-1.79],0.5351327765087373
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23686,1674,0.98 [0.89-1.08],0.7588382141666226
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23688,1670,0.99 [0.90-1.09],0.809972400399968
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,22403,31,1.20 [0.69-2.09],0.524938216346736
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23562,1068,0.99 [0.88-1.12],0.9220871929825076
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21046,774,1.12 [0.99-1.27],0.0779192548002653
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23836,105,1.17 [0.86-1.61],0.3198905564246221
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,23606,31,0.78 [0.33-1.81],0.5596629221296314
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22571,77,1.01 [0.66-1.55],0.9654687027902568
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22593,99,0.83 [0.53-1.30],0.4229580190396992
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",20381,109,0.95 [0.65-1.40],0.7961523541881759
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22283,105,1.03 [0.71-1.50],0.8851884451345214
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1485,57,0.88 [0.50-1.57],0.6761108588795849
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1581,166,0.88 [0.63-1.22],0.4448508167888583
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22213,35,0.54 [0.21-1.38],0.1992473814091113
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1457,29,1.18 [0.66-2.10],0.57322161047783
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23488,1310,1.00 [0.90-1.11],0.9773279811029136
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23634,59,1.13 [0.73-1.76],0.5783881510668547
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21939,245,1.25 [1.03-1.51],0.0263554961003116
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,20618,346,1.08 [0.89-1.31],0.4470159711955537
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23760,147,0.87 [0.61-1.25],0.4618055477575929
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23191,49,1.05 [0.60-1.83],0.8613077536438957
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Angina pectoris,22748,691,0.96 [0.82-1.12],0.5717555225041122
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23235,93,1.09 [0.75-1.58],0.6671935564171829
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23169,27,1.32 [0.76-2.29],0.3329308468640634
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23236,94,1.13 [0.79-1.63],0.5030975297852261
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,16926,787,1.03 [0.90-1.17],0.7107995359795483
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,AV-block,21700,158,0.94 [0.68-1.30],0.7120784096812627
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23812,225,0.80 [0.59-1.09],0.152611825863878
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiac arrest,16231,92,1.07 [0.73-1.56],0.7467560971251512
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cardiomyopathy,21656,114,0.66 [0.41-1.06],0.0841302630695354
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",21614,72,0.77 [0.45-1.34],0.362158232010271
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23844,15,1.36 [0.66-2.79],0.4010297873541083
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Conduction disorders,22006,464,1.09 [0.92-1.29],0.3287623120446644
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23215,1166,1.03 [0.92-1.15],0.6334950356183666
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22143,5225,0.95 [0.90-1.01],0.0972369330230763
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22836,154,0.91 [0.65-1.28],0.6011273414104223
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Endocarditis,21582,40,1.11 [0.64-1.94],0.7067302327256646
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23735,442,0.94 [0.78-1.15],0.5636495511628625
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertension,22635,4257,0.96 [0.90-1.02],0.1618876434397551
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, essential",22643,4265,0.96 [0.90-1.02],0.1500052945918888
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23692,48,1.28 [0.83-1.97],0.2733840935387396
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",18457,79,1.14 [0.78-1.66],0.4983690986513555
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18417,39,1.33 [0.86-2.05],0.1975977929210786
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Hypotension,23757,591,0.84 [0.69-1.01],0.0565982175482729
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,23384,57,0.93 [0.53-1.64],0.8055742671368826
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",23352,1295,1.00 [0.90-1.11],0.9962995293359888
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23649,270,0.81 [0.61-1.08],0.1543742053472893
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Left bundle-branch block,21724,182,1.12 [0.86-1.45],0.3974297418826927
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23623,523,0.99 [0.83-1.18],0.900973125953198
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",22482,425,0.98 [0.81-1.19],0.8532708901080154
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23793,105,0.86 [0.55-1.34],0.5039482299133156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23829,182,1.01 [0.76-1.35],0.9222136592855072
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Oesophageal varices,22713,31,1.45 [0.94-2.25],0.0950709801373159
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other aneurysm,23181,39,0.68 [0.30-1.52],0.3435324253937537
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arrhythmias,21764,222,0.87 [0.66-1.17],0.3633541328686962
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23201,59,1.29 [0.88-1.89],0.1926338307033526
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23270,128,1.33 [1.03-1.70],0.0278022941892902
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,21653,111,0.88 [0.59-1.33],0.5530358726185265
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other disorders of veins,22743,61,1.23 [0.83-1.82],0.3051875602534963
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22727,45,1.02 [0.57-1.81],0.9536644661954496
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23162,34,0.48 [0.18-1.26],0.1368179632684645
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22760,78,0.80 [0.47-1.36],0.4141445709017333
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22054,512,1.01 [0.85-1.19],0.9522953132866354
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23206,40,0.83 [0.41-1.69],0.607090871048239
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23444,302,1.07 [0.87-1.32],0.5211772893098798
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23454,137,1.13 [0.83-1.52],0.4389178121882355
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",23333,205,1.08 [0.83-1.39],0.5723697366497835
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16345,206,1.02 [0.79-1.33],0.8523105477638734
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23302,181,0.99 [0.73-1.33],0.922002802383393
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22897,215,0.95 [0.72-1.26],0.7320804184245999
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23603,286,0.93 [0.73-1.19],0.5553116912536347
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23806,282,1.04 [0.83-1.31],0.7122943771978683
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Right bundle-branch block,21687,145,0.99 [0.71-1.37],0.9442464277775552
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23451,134,1.16 [0.86-1.55],0.3366470304737959
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23225,97,1.06 [0.73-1.54],0.7711699125324402
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23643,316,0.83 [0.64-1.07],0.1497137460215949
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23621,348,0.76 [0.59-0.99],0.0414294277323971
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,23365,50,0.46 [0.20-1.05],0.0647210247203879
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23190,49,1.12 [0.69-1.83],0.6378427400949177
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23494,115,1.31 [1.01-1.70],0.0407196250727305
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23257,157,0.85 [0.59-1.21],0.366326792397478
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Varicose veins,22951,269,0.97 [0.76-1.23],0.7817530288860957
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23152,45,1.07 [0.62-1.85],0.8111540649757951
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23686,449,0.91 [0.75-1.11],0.3531653196100217
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23700,319,1.17 [0.97-1.41],0.0917035495773401
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21232,1225,0.98 [0.88-1.09],0.7340551858889808
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Any mental disorder,23183,3176,0.96 [0.90-1.03],0.2809938746833633
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23646,371,1.13 [0.94-1.35],0.1979607970403719
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",21464,1457,0.88 [0.79-0.99],0.0271825996068599
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20084,77,1.12 [0.77-1.63],0.5439135560081654
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Smoking dependency,23363,1328,0.93 [0.83-1.05],0.23082188180374
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21528,1521,0.98 [0.88-1.08],0.6582565744672435
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter V Mental and behavioural disorders,Vascular dementia,23745,17,1.37 [0.71-2.63],0.3525017453223574
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Alzheimer disease,23843,63,0.95 [0.58-1.56],0.8411856506648552
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Bell's palsy,22397,68,0.93 [0.57-1.52],0.7658679328684292
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22748,419,0.97 [0.80-1.17],0.7603179827883826
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral cysts,23529,178,0.97 [0.72-1.30],0.8240712108152862
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23768,187,0.93 [0.68-1.26],0.6204589942412374
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23714,22,1.64 [1.08-2.50],0.0206852541714252
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23833,49,0.83 [0.44-1.56],0.5536780862790757
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23403,52,1.09 [0.67-1.77],0.7381898921516753
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Epilepsy,22493,222,1.11 [0.88-1.40],0.3649038774117279
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23418,1147,0.96 [0.85-1.08],0.5029172230805583
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23816,167,1.17 [0.91-1.51],0.2132551219075167
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23398,1424,0.92 [0.82-1.02],0.1152809808325767
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Generalized epilepsy,23518,44,1.04 [0.61-1.80],0.8742710588454468
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hemiplegia,23717,136,0.85 [0.58-1.25],0.4127595931686241
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Hydrocephalus,23395,44,1.14 [0.69-1.88],0.6182974575224074
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23822,59,1.09 [0.69-1.72],0.708171008284601
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22393,64,0.74 [0.42-1.33],0.3150965637234433
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22399,70,0.95 [0.59-1.54],0.8394952276436534
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Memory loss,23713,65,0.73 [0.40-1.35],0.318745161291035
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Migraine,22632,361,1.02 [0.85-1.24],0.8077127766941691
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23767,327,1.07 [0.88-1.30],0.5001118274517395
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Motor neuron disease,17327,91,1.20 [0.87-1.65],0.2723879320221251
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23658,130,0.86 [0.59-1.25],0.4261440237422288
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23314,985,0.88 [0.77-1.00],0.0585792320276483
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Neurological diseases,22578,2631,0.94 [0.87-1.02],0.1286229843542066
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23757,65,0.59 [0.30-1.16],0.1255422723083558
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22664,335,0.82 [0.64-1.05],0.1133545021419655
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23784,203,0.97 [0.73-1.28],0.8138666601244565
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,19877,276,0.91 [0.72-1.17],0.4764241344977273
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23403,52,0.72 [0.37-1.41],0.3342590291117939
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23453,102,0.95 [0.64-1.42],0.8190102724325099
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23720,71,0.76 [0.43-1.33],0.3370131946651127
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22415,86,0.77 [0.47-1.28],0.320484828172263
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other headache syndromes,22327,56,1.26 [0.85-1.87],0.2551566699993379
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other neurological diseases,23736,385,0.96 [0.79-1.18],0.7218261673718991
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Other sleep disorders,22774,503,0.73 [0.59-0.91],0.0045260754682322
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Parkinson's disease,23830,75,1.37 [1.02-1.83],0.0350265323163494
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23406,55,0.96 [0.57-1.63],0.8918526068281473
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Restless leg syndrome,23842,33,0.76 [0.33-1.72],0.5092422562524277
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Sleep apnoea,23635,442,0.78 [0.63-0.98],0.0296733573129697
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23613,32,0.85 [0.37-1.91],0.6862550382662626
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23828,115,1.23 [0.92-1.63],0.1592132884066852
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22356,27,0.89 [0.40-1.98],0.7682069667781457
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23843,64,0.94 [0.57-1.55],0.8110303445883023
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23733,16,1.41 [0.73-2.70],0.3048916521501842
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23418,34,0.59 [0.24-1.47],0.2599649116599313
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23528,185,1.07 [0.81-1.40],0.6434343832372686
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23772,168,1.05 [0.79-1.41],0.721721260622953
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23189,33,1.52 [1.02-2.29],0.0420240331307091
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23222,66,0.69 [0.38-1.27],0.2380559771411434
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23760,29,1.04 [0.52-2.07],0.906437722874994
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23677,58,1.04 [0.63-1.71],0.8822603414594816
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1460,32,1.24 [0.72-2.12],0.4363027357745549
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1725,68,1.03 [0.64-1.64],0.9161068999512958
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23459,75,0.94 [0.59-1.51],0.8059744109020226
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23738,540,0.92 [0.77-1.10],0.3799075273938106
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23570,414,1.08 [0.91-1.29],0.3900912323975262
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23276,120,1.30 [1.00-1.69],0.0469850113190578
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23762,419,1.09 [0.92-1.30],0.3178531774258166
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23835,50,1.25 [0.82-1.90],0.3021931490721011
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23696,353,1.13 [0.94-1.36],0.1763294309606454
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23807,188,0.99 [0.75-1.32],0.9627517633738492
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23789,116,0.74 [0.47-1.16],0.1880880861258733
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23171,15,0.91 [0.30-2.78],0.8695383479730883
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23182,26,0.94 [0.42-2.13],0.88374144914606
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23186,30,1.50 [0.97-2.31],0.067215926101513
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23803,331,0.98 [0.79-1.22],0.8750621042829213
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23552,80,0.84 [0.51-1.38],0.4927757863180709
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23364,21,1.01 [0.44-2.34],0.9768635365538014
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23679,60,0.93 [0.55-1.59],0.8025154439217482
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23749,130,1.05 [0.75-1.45],0.7858427444168058
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23489,146,1.15 [0.88-1.52],0.3079027302241763
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23739,66,0.63 [0.34-1.20],0.1587729911568018
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23687,215,1.09 [0.85-1.40],0.4751830826357134
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23482,98,1.08 [0.75-1.55],0.6837984255589096
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23224,926,0.91 [0.79-1.05],0.1828821506687429
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23727,108,1.06 [0.75-1.52],0.7289399546898778
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23821,97,1.15 [0.82-1.62],0.4028376472957198
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23384,228,1.06 [0.83-1.36],0.6337727080080855
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23655,36,0.82 [0.39-1.76],0.6173111701371068
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23819,34,1.01 [0.53-1.95],0.9664026800711554
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23192,36,1.51 [1.05-2.18],0.0255295472444582
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23256,100,0.91 [0.60-1.39],0.6663795071729035
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23255,57,0.54 [0.26-1.13],0.1010302097540393
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23391,48,0.91 [0.50-1.64],0.7458798192748655
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23241,43,0.61 [0.28-1.36],0.2283885513011322
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23518,46,0.39 [0.16-0.94],0.0363108993428811
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23553,81,1.14 [0.77-1.68],0.509627707376114
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23231,75,1.29 [0.92-1.80],0.1418687340032579
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,23302,104,1.19 [0.88-1.60],0.2598315456122397
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23227,29,0.62 [0.23-1.67],0.3413444873590596
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23018,720,1.02 [0.89-1.18],0.7445857341584474
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23200,44,0.95 [0.52-1.73],0.8644004708003509
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23652,268,0.99 [0.78-1.25],0.9101710517448076
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23415,31,1.12 [0.61-2.06],0.7084365616821465
MED21,Mediator of RNA polymerase II transcription subunit 21,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23494,110,1.15 [0.83-1.57],0.401430930691686
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23667,58,1.13 [0.73-1.74],0.586814129580189
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23803,78,0.89 [0.55-1.43],0.6195244319622255
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23734,122,0.72 [0.46-1.12],0.1451726195885807
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23658,49,1.10 [0.67-1.80],0.7072105618509782
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,23660,51,0.90 [0.50-1.61],0.7154125751911639
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23761,460,1.01 [0.84-1.20],0.9313878233480696
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23590,289,0.99 [0.78-1.24],0.9065016388192956
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23384,83,1.30 [0.95-1.79],0.1053537541878477
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,23367,66,0.80 [0.45-1.41],0.4349435226793174
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute pharyngitis,23588,69,1.00 [0.63-1.59],0.9992098275355772
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23729,210,1.05 [0.82-1.35],0.6820077345210935
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23574,55,0.72 [0.37-1.41],0.3379854024490958
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,All influenza,22722,69,0.74 [0.42-1.33],0.3179406201514195
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22721,68,0.76 [0.43-1.36],0.3589840614460886
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Allergic asthma (mode),17629,117,1.14 [0.85-1.54],0.3872603073167959
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Allergic rhinitis,23716,272,0.84 [0.65-1.10],0.2008420046623646
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18910,1527,1.04 [0.95-1.14],0.4132225429341868
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19013,1501,1.03 [0.94-1.13],0.4831484336309629
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23596,84,1.36 [1.00-1.83],0.0476341236746067
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",22703,50,1.46 [1.03-2.07],0.0313730967950845
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Bronchiectasis,21201,155,0.92 [0.66-1.29],0.6367813644985121
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21080,34,0.85 [0.61-1.17],0.3174515915322821
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23077,2031,1.00 [0.92-1.09],0.9810680309174769
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22559,58,0.85 [0.48-1.50],0.5687313004030332
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Chronic sinusitis,22644,143,1.11 [0.83-1.48],0.4873398552436215
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23752,615,0.96 [0.81-1.13],0.5967056221586018
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Deviated nasal septum,22622,121,1.02 [0.73-1.43],0.8965990915888573
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22158,3671,0.96 [0.90-1.02],0.1745430131313492
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22839,338,0.97 [0.78-1.20],0.7858400158466575
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Early onset COPD,23577,440,0.86 [0.70-1.07],0.1739574082893765
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Emphysema,21205,159,1.07 [0.80-1.44],0.6482131597722067
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22728,100,1.21 [0.88-1.66],0.2476001566083521
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23684,1031,1.00 [0.89-1.13],0.9566101498115692
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Interstitial lung disease,22748,120,1.12 [0.81-1.54],0.492596508361126
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Later onset COPD,22583,175,1.14 [0.89-1.47],0.3018193493461419
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23836,132,1.04 [0.75-1.45],0.7949189978694787
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Nasal polyp,22603,102,0.97 [0.66-1.44],0.8944635951253013
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23650,548,0.90 [0.75-1.07],0.2310345594330651
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of pleura,23688,1083,0.97 [0.86-1.10],0.6196390520835311
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23276,775,0.92 [0.79-1.06],0.2462613981925457
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other pleural conditions,22638,33,0.77 [0.34-1.75],0.5371811058006895
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23791,176,0.96 [0.71-1.30],0.8069013620574617
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23773,743,0.92 [0.79-1.07],0.2709528495235332
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural effusion,23122,517,1.17 [1.01-1.35],0.0362979139875013
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pleural plaque,22652,47,0.80 [0.40-1.59],0.5207679615530694
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23499,846,1.02 [0.89-1.16],0.7705677462844028
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23819,115,1.06 [0.75-1.49],0.7594852017740569
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pneumothorax,22660,55,0.82 [0.45-1.52],0.5375573462902162
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pollen allergy,23812,232,0.92 [0.70-1.20],0.5376633994854001
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Pulmonary oedema,23651,36,0.41 [0.15-1.12],0.0818422394271786
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Respiratory insufficiency,17544,32,0.93 [0.46-1.85],0.8282887763578343
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23630,528,0.90 [0.75-1.08],0.2749978484637481
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22773,272,0.84 [0.64-1.09],0.1974198359318867
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Viral pneumonia,22819,166,0.77 [0.53-1.11],0.1581920067919454
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23613,143,0.82 [0.56-1.20],0.2995207948036118
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13726,82,1.20 [0.84-1.71],0.310666037570979
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18233,56,0.64 [0.32-1.28],0.2029786957230773
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute appendicitis,23668,133,0.83 [0.57-1.21],0.3320768357659928
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute gastritis,19051,60,1.26 [0.86-1.85],0.238883450243957
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute pancreatitis,22449,148,0.99 [0.72-1.37],0.967768546411096
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Acute peritonitis,23460,58,1.33 [0.94-1.89],0.1092446595550534
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23169,73,0.86 [0.51-1.47],0.5812009767264366
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Barrett oesophagus,19298,307,1.02 [0.82-1.26],0.886924413364876
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22350,49,1.36 [0.92-2.00],0.124889947480649
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23491,49,1.36 [0.92-2.02],0.1203371923502186
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholecystitis,22457,156,0.88 [0.62-1.24],0.4602764017122098
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Cholelithiasis,23110,809,1.04 [0.92-1.18],0.5034636988179764
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic gastritis,19206,215,1.16 [0.92-1.46],0.2064235930963719
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22339,38,1.36 [0.89-2.08],0.1581250358865543
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23716,72,1.33 [0.95-1.85],0.0993408518977145
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Coeliac disease,22599,97,1.66 [1.38-2.00],5.27928961444824e-08
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Collagenous colitis,22487,48,0.36 [0.15-0.87],0.0231039174038246
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23673,179,0.98 [0.74-1.31],0.909929761680606
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Constipation,23658,1004,0.94 [0.83-1.07],0.3323844078409657
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn disease,22518,79,0.81 [0.49-1.35],0.4179163387196182
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23540,53,0.87 [0.48-1.58],0.6457047959577288
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22516,77,0.88 [0.54-1.42],0.5895860472785084
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Dental caries,23123,227,1.06 [0.83-1.34],0.6463888994802389
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22033,1550,1.11 [1.02-1.21],0.0180603437349166
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of appendix,23706,171,0.89 [0.65-1.22],0.4676055627468342
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of liver,23739,643,1.09 [0.95-1.25],0.2224757537469407
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22320,3329,1.03 [0.97-1.10],0.3024846146456459
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23425,529,1.07 [0.92-1.25],0.3596662040653114
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23773,371,1.26 [1.08-1.47],0.003213539417145
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23009,113,1.10 [0.79-1.53],0.5821486949951831
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of salivary glands,22874,60,1.17 [0.78-1.77],0.4537735275461271
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23599,1097,1.10 [0.99-1.22],0.0621693659988785
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diseases of tongue,22879,107,1.04 [0.73-1.48],0.8347824321586896
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23397,1096,1.03 [0.92-1.15],0.5809640913783994
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20293,2116,0.94 [0.86-1.03],0.174312099516362
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Duodenal ulcer,19121,130,0.85 [0.57-1.26],0.4211658848326426
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23780,101,0.81 [0.51-1.29],0.3744186448037208
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23725,73,1.20 [0.84-1.71],0.3142524499708807
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23186,90,1.35 [1.02-1.80],0.0358431839489623
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18330,153,0.97 [0.71-1.32],0.8398448353540053
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Functional dyspepsia,19435,444,1.09 [0.92-1.29],0.3229528956361104
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastric ulcer,19240,249,1.09 [0.86-1.37],0.4856064581585866
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20927,1936,0.98 [0.90-1.08],0.7247863980496878
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19354,363,1.01 [0.82-1.24],0.922468825752316
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19410,6918,1.02 [0.97-1.07],0.4174832923772429
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,GI-bleeding,23376,874,0.98 [0.86-1.12],0.813216797541673
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22956,60,1.08 [0.68-1.70],0.7469057937799146
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,18958,1101,0.93 [0.82-1.05],0.2430486686901347
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23142,46,0.99 [0.55-1.78],0.9794781275643438
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Hernia,22826,2343,1.12 [1.04-1.20],0.002373256995302
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impacted teeth,23734,68,1.25 [0.88-1.77],0.2170119556665308
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Impaction of intestines,18207,30,0.77 [0.33-1.80],0.5407545196803863
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Inguinal hernia,21074,591,1.16 [1.02-1.33],0.0267209437293462
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",20552,69,1.06 [0.69-1.65],0.7786266359124381
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18240,63,0.78 [0.44-1.40],0.4020936203070934
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22618,116,1.60 [1.34-1.92],2.3382137811083305e-07
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,18680,503,0.75 [0.61-0.93],0.0074763790229044
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23819,334,1.08 [0.89-1.31],0.4565112390806052
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23041,602,1.06 [0.92-1.23],0.4008961596226454
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23199,760,1.00 [0.87-1.15],0.9910487078006524
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19117,126,1.07 [0.77-1.49],0.6724723041192198
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oesophagitis,19415,424,1.05 [0.88-1.26],0.6095773159566183
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23806,116,0.93 [0.64-1.35],0.6908407147921789
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20526,43,0.82 [0.41-1.64],0.5772471663794564
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19309,1132,1.03 [0.92-1.14],0.6368889275343413
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22469,168,1.25 [0.99-1.57],0.0572207439175912
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22440,139,1.02 [0.75-1.38],0.9158657098251656
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestine,19499,1322,0.97 [0.87-1.08],0.6164746699135562
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of intestines,22407,4230,0.96 [0.90-1.02],0.1474088711728198
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22881,167,0.93 [0.69-1.27],0.6679561072227453
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of liver,23611,515,1.10 [0.95-1.29],0.2038883629280654
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,19459,468,1.07 [0.91-1.27],0.3957280835330928
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22371,70,0.73 [0.41-1.31],0.2976891531666535
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23728,326,1.24 [1.05-1.47],0.010610015826487
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,19657,666,0.97 [0.83-1.13],0.6678024940352416
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23389,887,0.99 [0.87-1.12],0.846240882652358
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23042,146,1.13 [0.86-1.50],0.3712103394248972
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19223,1046,0.93 [0.82-1.05],0.2397046005830337
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),20513,1522,1.08 [0.98-1.18],0.1017707248316497
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23167,71,1.32 [0.96-1.82],0.0852971836926328
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23100,661,1.02 [0.88-1.18],0.8288931259101444
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18380,203,0.78 [0.56-1.08],0.1345786647999687
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23711,86,1.19 [0.85-1.65],0.3087127238743039
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,18480,303,0.84 [0.65-1.08],0.178332269053524
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22627,125,1.20 [0.91-1.59],0.191639236304781
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23834,55,1.04 [0.63-1.71],0.8745274918805646
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22910,117,1.04 [0.75-1.46],0.7982377544058086
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Toxic colitis,22460,21,0.38 [0.10-1.41],0.1470246312366965
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19156,165,1.00 [0.74-1.36],0.9884682168298188
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ulcerative colitis,22568,129,1.02 [0.73-1.42],0.9113694915147376
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22550,111,1.04 [0.74-1.47],0.8153698447659612
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Umbilical hernia,20717,234,0.99 [0.77-1.28],0.9580491839751432
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18270,93,1.05 [0.72-1.53],0.7905116173935623
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Ventral hernia,20682,199,1.19 [0.95-1.49],0.1352882069770278
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XI Diseases of the digestive system,Volvulus,18235,58,1.07 [0.67-1.71],0.7646502853391551
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23804,136,1.08 [0.80-1.46],0.6120700611046663
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23611,72,0.84 [0.50-1.41],0.4991098351492875
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,22559,131,0.95 [0.67-1.34],0.7735644295574685
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23281,479,0.91 [0.76-1.11],0.359452681197142
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22981,179,1.15 [0.91-1.47],0.2495013428302311
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22574,146,1.24 [0.96-1.60],0.0937847066188125
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23618,202,1.01 [0.77-1.31],0.9691107358059208
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23757,341,1.00 [0.81-1.23],0.9987363019942866
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23452,36,0.69 [0.30-1.57],0.3754076369521802
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22564,2216,0.99 [0.91-1.08],0.8246647474299182
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23440,369,0.96 [0.78-1.18],0.6943458590226639
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23328,257,0.92 [0.71-1.19],0.531353318136323
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23490,688,0.96 [0.82-1.11],0.5537711700990777
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23831,40,1.00 [0.55-1.82],0.9961177494420989
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,22482,54,0.92 [0.52-1.62],0.7695168112013206
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23108,37,1.19 [0.71-2.00],0.5133617975253347
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23612,196,0.91 [0.68-1.23],0.549460476941122
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22683,255,1.07 [0.86-1.33],0.5479704219430164
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,22462,34,0.79 [0.36-1.74],0.5614237154323605
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23773,62,1.13 [0.74-1.73],0.568163086737925
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22919,117,0.65 [0.40-1.04],0.073172353653954
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23673,134,1.04 [0.75-1.44],0.8194672909701244
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23440,24,0.64 [0.22-1.88],0.416322294554272
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,22474,46,0.51 [0.22-1.16],0.1101857990345705
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23391,963,1.01 [0.90-1.15],0.8105857963875529
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22713,285,1.01 [0.81-1.26],0.9124826248250988
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,22465,37,0.85 [0.41-1.75],0.6582276075085043
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23772,233,1.03 [0.81-1.32],0.7835602535342749
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23471,55,1.32 [0.90-1.95],0.1554938514082968
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23730,191,1.08 [0.84-1.40],0.5485555037613685
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23817,149,1.08 [0.81-1.44],0.6037882235769654
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,22538,110,0.82 [0.53-1.25],0.3495642120469281
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22596,168,1.15 [0.89-1.48],0.2765776470987344
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23812,144,1.07 [0.79-1.44],0.6720521664992726
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22542,114,0.98 [0.68-1.42],0.9306320237929636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23815,104,1.03 [0.71-1.48],0.8916492481881242
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20890,117,0.87 [0.59-1.29],0.498980473483126
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22234,4024,0.94 [0.88-1.00],0.0398099837062595
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21075,2865,0.90 [0.83-0.97],0.0084938026058277
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20858,85,1.01 [0.67-1.51],0.965420890205148
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21363,135,0.64 [0.41-1.00],0.0506505993296775
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21370,142,0.80 [0.55-1.17],0.2496682473656054
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23644,101,0.86 [0.56-1.33],0.5025017663853295
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21271,43,1.06 [0.61-1.86],0.8293949268386807
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,18873,663,0.96 [0.83-1.12],0.6069641600010809
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23789,114,0.91 [0.62-1.35],0.6407330183125173
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21480,252,0.83 [0.63-1.11],0.207705353473385
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20819,5392,0.97 [0.92-1.02],0.2737566334931328
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22635,92,0.95 [0.63-1.45],0.8226502133931559
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20875,102,0.99 [0.67-1.46],0.9616980098313708
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21310,537,0.77 [0.63-0.94],0.0096795284229457
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23057,1829,0.96 [0.87-1.05],0.3921308217097874
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20974,201,1.11 [0.87-1.41],0.40903239052948
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21033,260,0.92 [0.72-1.18],0.4928586210235763
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20908,135,0.51 [0.32-0.82],0.0057159341318292
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23378,34,1.50 [1.00-2.25],0.0518418214027727
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19341,1131,0.89 [0.79-1.01],0.0790869840331103
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18550,340,1.03 [0.84-1.26],0.7893763892353445
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23795,330,1.05 [0.85-1.29],0.6539488432771003
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18277,67,0.85 [0.50-1.45],0.549101084560199
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18513,303,0.87 [0.68-1.11],0.2549217267868109
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21061,288,0.91 [0.71-1.16],0.4435783221173448
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18869,659,0.88 [0.74-1.04],0.1224182141024665
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21253,25,0.98 [0.46-2.11],0.9666885903552922
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21715,487,0.99 [0.84-1.18],0.9504952778470492
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21477,249,0.81 [0.61-1.08],0.1569437874142054
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18822,612,0.86 [0.73-1.03],0.1006723679005845
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20843,70,0.94 [0.58-1.52],0.8087373089441141
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20826,53,1.11 [0.70-1.77],0.6534133190501759
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22593,50,0.73 [0.36-1.46],0.3744347608978586
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23551,1008,1.04 [0.93-1.17],0.5066338566276293
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23117,574,1.20 [1.05-1.37],0.008475554321351
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23737,301,0.90 [0.70-1.14],0.381778436303079
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,19764,1554,0.91 [0.81-1.01],0.0660498591115822
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18273,63,0.56 [0.29-1.11],0.09654601258905
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20841,68,0.70 [0.38-1.26],0.2316903342007209
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18235,25,1.47 [0.91-2.38],0.1126912866293353
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18307,97,1.25 [0.93-1.68],0.1437355697712708
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22745,202,0.77 [0.56-1.08],0.12674291299276
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22754,211,0.99 [0.75-1.29],0.927183653718452
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23807,74,0.94 [0.59-1.52],0.8156752529637178
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22590,1362,0.97 [0.87-1.08],0.5936811760191896
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20880,107,1.09 [0.79-1.52],0.590389100559972
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18319,109,0.88 [0.59-1.33],0.5544844011400608
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21783,555,0.96 [0.81-1.14],0.6404222340531884
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,19989,1779,0.91 [0.83-1.01],0.0629290647386734
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23396,52,1.51 [1.10-2.08],0.0110277940249561
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23819,69,0.84 [0.49-1.42],0.5117329544645273
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20843,70,0.95 [0.59-1.54],0.840474686391383
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21737,964,1.00 [0.89-1.13],0.9518725273064564
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20832,59,0.97 [0.58-1.62],0.900177632581216
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19177,967,0.91 [0.80-1.04],0.1847196429549228
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22635,92,0.60 [0.35-1.05],0.0727811803689372
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20832,59,0.73 [0.39-1.35],0.3177617501818544
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21331,103,1.06 [0.74-1.52],0.7397701434025306
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21117,344,1.06 [0.87-1.28],0.5597336891045523
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23534,190,1.18 [0.94-1.50],0.1549498281663655
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21639,411,1.00 [0.82-1.21],0.9699809777739944
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23746,286,0.88 [0.68-1.13],0.3062672503580422
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23827,33,0.90 [0.43-1.87],0.767618788674636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20954,181,0.88 [0.64-1.21],0.4315602948129632
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19108,532,0.80 [0.66-0.98],0.0307361402770394
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21205,432,1.03 [0.87-1.23],0.7256179866155167
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20922,149,1.01 [0.74-1.38],0.9321059149110232
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18243,33,1.30 [0.79-2.13],0.3074024353071861
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19743,1533,0.96 [0.86-1.06],0.3779539802567259
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,18602,392,0.68 [0.53-0.87],0.0023124322732699
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23421,77,1.54 [1.18-2.02],0.0016297439395949
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23776,43,1.12 [0.67-1.89],0.6589099291720953
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",22448,24,0.31 [0.09-1.08],0.0662581425293185
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18281,71,0.80 [0.47-1.37],0.4163579646790364
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21306,78,0.95 [0.59-1.51],0.8159369264169942
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18514,304,0.91 [0.72-1.16],0.4617750835065509
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21010,237,0.89 [0.68-1.17],0.3952583082369453
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21414,186,0.95 [0.71-1.28],0.7468692082477701
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21321,93,0.53 [0.30-0.94],0.0292720733137645
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20152,41,0.75 [0.36-1.58],0.4535124647790267
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23830,36,1.06 [0.57-1.95],0.8566217588105636
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21297,524,0.93 [0.78-1.11],0.3974283695580416
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],23422,78,0.94 [0.59-1.48],0.7818268257461255
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22900,2127,0.96 [0.88-1.05],0.3505905971306353
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20874,101,1.01 [0.69-1.47],0.9500436831508984
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21544,316,1.02 [0.83-1.27],0.8342198980856453
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22613,167,0.99 [0.73-1.34],0.9277685426693112
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,21359,131,0.89 [0.61-1.30],0.5543660477523982
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22165,937,0.91 [0.79-1.04],0.1635534185107726
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21841,613,0.91 [0.77-1.08],0.2974629274758444
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20812,39,0.68 [0.31-1.52],0.3500375876589815
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23478,134,1.04 [0.75-1.43],0.8303903545350019
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20907,134,0.84 [0.58-1.23],0.3717921788542311
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20826,53,1.02 [0.61-1.70],0.9479853073009992
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18243,33,1.63 [1.17-2.26],0.0038720280688369
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Acute renal failure,23392,726,0.90 [0.76-1.05],0.1814546482308234
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9660,63,0.99 [0.62-1.56],0.9489669728181284
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,12877,70,1.19 [0.82-1.72],0.3686344015866308
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23581,268,0.95 [0.74-1.21],0.6766617805602726
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23369,56,1.05 [0.64-1.71],0.8547738631673134
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23216,550,1.20 [1.05-1.38],0.0087741282365045
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23690,18,0.96 [0.37-2.48],0.9275004760892834
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23698,157,1.09 [0.82-1.45],0.5570341319027494
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Cystitis,21891,135,1.07 [0.78-1.47],0.6631946029978156
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Dialysis,22707,41,1.27 [0.81-1.99],0.3010829836099842
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10304,982,0.96 [0.85-1.09],0.5553271717959665
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Disorders of breast,12980,173,1.04 [0.79-1.37],0.7696552034536316
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Endometriosis,9712,115,1.00 [0.72-1.40],0.9808109790450794
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",9927,330,0.88 [0.71-1.10],0.267715806544238
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,9973,376,0.98 [0.81-1.19],0.8465869677341162
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20064,3663,1.00 [0.94-1.07],0.9404175196768088
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23726,54,1.26 [0.86-1.85],0.2296745020846673
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydrocele,9394,72,0.67 [0.37-1.22],0.1916197153379414
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,22592,191,0.87 [0.64-1.19],0.3845934918772263
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,9975,653,1.01 [0.86-1.17],0.9412605900295592
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,12864,206,0.90 [0.68-1.19],0.4566082386146399
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9413,91,0.77 [0.46-1.27],0.3004125883686734
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Irregular menses,12874,106,0.82 [0.55-1.25],0.3583391926572669
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Menorrhagia,9856,259,0.91 [0.72-1.16],0.4430321754235015
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,21813,57,0.91 [0.52-1.58],0.7329211245016112
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,10806,1209,0.99 [0.89-1.10],0.8757813687005768
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9369,47,0.86 [0.45-1.63],0.6435893877637769
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9680,83,1.14 [0.81-1.59],0.4499327960934461
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23834,35,1.14 [0.63-2.06],0.6592016677089392
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23838,39,1.07 [0.60-1.89],0.8223825891026109
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23082,1326,1.00 [0.90-1.12],0.9399468877118816
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22176,420,1.09 [0.92-1.30],0.3102972457123183
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,12860,53,0.84 [0.47-1.51],0.5655559027602263
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23800,259,1.26 [1.05-1.52],0.013223096588021
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9458,136,0.88 [0.61-1.27],0.4905651685610015
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9427,105,1.01 [0.69-1.47],0.9622841192313796
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9387,65,1.00 [0.62-1.63],0.986301365955424
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23812,49,1.17 [0.74-1.85],0.4911085061102302
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22727,971,1.02 [0.90-1.15],0.7470714465151014
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,12763,105,0.93 [0.64-1.36],0.7082665337814393
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9668,71,0.89 [0.55-1.44],0.639736005156399
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",9795,198,0.79 [0.57-1.08],0.1333691245206826
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9648,51,1.32 [0.92-1.91],0.1327468826846979
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9686,89,1.00 [0.67-1.48],0.9813043458152966
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,22622,221,0.89 [0.67-1.18],0.4286208074681121
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23629,88,1.37 [1.03-1.82],0.0283243622276003
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,9752,155,1.08 [0.82-1.41],0.5875555734248191
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9666,69,1.04 [0.68-1.57],0.8680188723595711
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,9953,356,1.06 [0.89-1.27],0.5136160933328076
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9652,55,1.05 [0.65-1.70],0.8379805079214739
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,9915,318,1.12 [0.94-1.34],0.2029835856220379
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23714,42,1.04 [0.59-1.84],0.9013930952800234
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9418,96,0.92 [0.60-1.41],0.7108705736978675
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23687,1286,1.03 [0.93-1.15],0.5540292295026406
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",22521,120,0.90 [0.61-1.31],0.5812837271990001
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,22720,54,1.20 [0.78-1.84],0.3975423603800628
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23374,61,0.99 [0.60-1.63],0.957261824058792
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21905,149,0.77 [0.52-1.13],0.1798948992881956
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23639,326,0.95 [0.76-1.18],0.6378561827545812
MED21,Mediator of RNA polymerase II transcription subunit 21,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9681,84,1.06 [0.74-1.53],0.7355196063150282
